Abstract
Phosphoryloxymethyl carbonates and carbamates of the type R 1 R 2 X-CO-O-CH2-O-PO3 −2 (X = O or N) were evaluated as potentially novel water-soluble collapsible prodrugs for alcohols and amines. These were prepared by reaction of α-chloromethyl chloroformate with the starting alcohol or amine to give the corresponding α-chloromethyl carbonate or carbamate, respectively. Reaction with silver dibenzyl phosphate followed by debenzylation by hydrogenolysis gave the desired products. The aqueous chemical stability of the phosphoryloxymethylcarbonyl derivatives of 2-indanol (3a), β-(3,4-dimethoxyphenyl)ethylamine (3b), and benzocaine (3c) were evaluated. The aqueous hydrolysis of 3a – 3c resulted in regeneration of the parent alcohol or amines. As expected, the hydrolytic behaviors of these derivatives were found to differ from that of simple alkyl and aryl phosphomonoesters. The rates of hydrolysis were extremely rapid, with the dianionic phosphate species possessing a higher reactivity than the monoanionic species. This was attributed to the proximity of the phosphate group to the carbonyl moiety. The carbamate derivatives, 3b and 3c, displayed greater chemical stability compared to the carbonate derivative, 3a. Alkaline phosphatases-mediated hydrolysis of the phosphate ester bond in 3c led to a rapid cascade reaction resulting in regeneration of the parent amine, benzocaine. Although the alcohol derivative described here appeared to be too chemically unstable to be ideal as a prodrug, the derivatives of the amines might have some use. They are expected to be cleaved in vivo by alkaline phosphatases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
L. E. Hare, K. C. Yeh, C. A. Ditzler, F. G. McMahon, and D. E. Duggan. Bioavailability of dexamethasone II. Dexamethasone phosphate. Clin. Pharmacol. Ther. 18:330–337 (1975).
H. Mollmann, P. Rohdewald, J. Barth, M. Verho, and H. Derendorf. Pharmacokinetics and dose linearity testing of methylprednisolone phosphate. Biopharm. Drug. Disp. 10:453–464 (1989).
K. I. Plaisance, G. L. Drusano, A. Forrest, R. J. Townsend, and H. C. Standiford. Pharmacokinetic evaluation of two dosage regiments of clindamycin phosphate. Antimicrob. Agents Chemother. 33:618–620 (1989).
N. Gerber, D. C. Mays, K. H. Donn, A. Laddu, R. M. Guthrie, P. Turlapaty, C. Y. Quon, and W. K. Riverburg. Safety, tolerance and pharmacokinetic of intravenous doses of the phosphate ester of 3-hydroxymethyl-5,5-diphenylhydantoin: A new prodrug of phenytoin. J. Clin. Pharmacol. 28:1023–1032 (1988).
S. A. Varia, S. Schuller, K. B. Sloan, and V. J. Stella. Phenytoin prodrugs IV: Hydrolysis of various 3-(hydroxymethyl)-phenytoin esters. J. Pharm. Sci. 73:1074–1080 (1984).
G. L. Amidon, D. Fleischer, and B. Stewart. Design of prodrugs for improved gastrointestinal absorption by intestinal enzyme targeting. In K. J. Widder and R. Green (eds.), Drug and Enzyme Targeting, Academic, New York, 1985, p. 360.
H. Mollmann, P. Rohdewald, E. W. Schmidt, V. Salomon, and H. Derendorf. Pharmacokinetics of triamcinolone acetonide and its phosphate ester. Eur. J. Clin. Pharmacol. 29:85–89 (1985).
A. Williams and R. A. Naylor. Evidence for SN2(P) mechanism in the phosphorylation of alkaline phosphatase by substrate. J. Chem. Soc. B 1973–1979 (1971).
A. S. Kearney and V. J. Stella. The in vitro enzymatic labilities of chemically distinct phosphomonoester prodrugs. Pharm. Res. 9:497–503 (1992).
P. O. Gunnarsson, S. B. Andersson, S. A. Johansson, T. Nilsson, and G. Plym-Forshell. Pharmacokinetics of estramustine phosphate. Eur. J. Clin. Pharmacol. 26:113–119 (1984).
J. Alexanders, R. Cargill, S. R. Michelson, and H. Schwam. (Acyloxy)alkyl carbamates as novel bioreversible prodrugs for amines: Increased permeation through biological membranes. J. Med. Chem. 31:318–322 (1988).
A. S. Kearney and V. J. Stella. Unpublished results.
A. J. Kirby and A. G. Varvoglis. The reactivity of phosphate esters. Monoester hydrolysis. J. Am. Chem. Soc. 89:415–423 (1967).
F. H. Westheimer. Monomeric metaphosphates. Chem. Rev. 81:313–326 (1981).
M. N. Nassar, B. J. Agha, and G. A. Digenis. Effects of structural variation on the rates of enzymatic and nonenzymatic hydrolysis of carbonates and carbamates esters. J. Pharm. Sci. 81:295–298 (1992).
V. J. Arai. Über die spontane spaltung der salolphosphorsäure und phenylphosphosalizysäure. J. Biochem. (Tokyo) 20:465–480 (1934).
R. Kluger and C.-H. Lam. General base catalysis in acidic solutions. Acceleration of intramolecular phosphonate-assisted amide hydrolysis. Can. J. Chem. 55:640–645 (1977).
H. Bundgaard and J. Hansen. Nucleophilic phosphate-catalyzed degradation of penicillins: Demonstration of a penicilloyl phosphate intermediate and transformation of ampicillin to a piperazinedione. Int. J. Pharm. 9:273–283 (1981).
V. J. Stella. Prodrugs: An overview and definition. In T. Higuchi and V. J. Stella (eds.), Prodrugs as Novel Drug Delivery Systems, American Chemical Society, Washington, DC, 1975, pp. 1-XX.
H. Lineweaver and D. Burk. The determination of enzyme dissociation constants. J. Am. Chem. Soc. 56:658–666 (1934).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Safadi, M., Oliyai, R. & Stella, V.J. Phosphoryloxymethyl Carbamates and Carbonates—Novel Water-Soluble Prodrugs for Amines and Hindered Alcohols. Pharm Res 10, 1350–1355 (1993). https://doi.org/10.1023/A:1018934200343
Issue Date:
DOI: https://doi.org/10.1023/A:1018934200343